Clinical Significance of Bone Marrow Blast Percentage in Patients with Myelofibrosis and the Effect of Ruxolitinib Therapy

Publication date: Available online 6 January 2021Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Lucia Masarova, Prithviraj Bose, Naveen Pemmaraju, Naval Daver, Lingsha Zhou, Sherry Pierce, Hagop Kantarjian, Zeev Estrov, Srdan Verstovsek
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research